Proto-Oncogenes: Requirements to Cause Cancer
Proto-Oncogenes: Requirements to Cause Cancer Proto-oncogenes play a critical role in the development of cancer. These genes, when mutated or activated, can transform into cancer-causing agents, known as oncogenes. Understanding the specific requirements for proto-oncogenes to cause cancer is essential in comprehending the complex process of carcinogenesis.
Research has shown that certain conditions must be met for proto-oncogenes to undergo malignant transformation. These include genetic alterations, such as mutations or rearrangements, that result in the aberrant activation of oncogenes. Additionally, environmental factors and epigenetic modifications can contribute to the activation of proto-oncogenes and their involvement in the development of cancer.
The role of proto-oncogenes in carcinogenesis cannot be underestimated. These genes serve as crucial drivers in the initiation and progression of various types of cancers. By understanding the requirements and mechanisms behind their transformation, researchers can identify potential therapeutic targets and develop personalized treatment approaches.
This article explores the functions of proto-oncogenes, the impact of mutations, their role in cancer initiation, and the factors influencing their activation. It also discusses the clinical implications of proto-oncogenes and the future directions for research in this field. Moreover, the article emphasizes the importance of early detection and prevention in combating proto-oncogene-related cancers.
Join us on this enlightening journey as we delve into the complex world of proto-oncogenes and their requirements to cause cancer. Stay tuned for the upcoming sections to gain a comprehensive understanding of the role these genes play in the development of this devastating disease.
Understanding Proto-Oncogenes and their Functions
Proto-oncogenes play a crucial role in the progression of cancer by promoting cell growth and division. These genes, when normal and properly regulated, are essential for the normal functioning and growth of cells. However, under certain conditions, such as genetic alterations or environmental factors, proto-oncogenes can transform into oncogenes, leading to uncontrolled cell growth and the development of tumors.
ACIBADEM Health Point: Your Health is Our Priority!
ACIBADEM Health Point, we are dedicated to providing exceptional healthcare services to our patients. With a team of highly skilled medical professionals and state-of-the-art facilities, we strive to deliver the highest standard of care to improve the health and well-being of our patients. What sets ACIBADEM Health Point apart is our patient-centered approach. We prioritize your comfort, safety, and satisfaction throughout your healthcare journey. Our compassionate staff ensures that you receive personalized care tailored to your unique needs, making your experience with us as seamless and comfortable as possible.Oncogenes, the activated form of proto-oncogenes, drive tumorigenesis by disrupting the balance between cell growth and cell death. They can affect various cell signaling pathways involved in processes such as cell proliferation, differentiation, and apoptosis. The aberrant activity of oncogenes can lead to the uncontrolled growth and division of cells, ultimately contributing to the development and progression of cancer.
One of the key roles of oncogenes in tumorigenesis is their ability to bypass the normal regulatory mechanisms that prevent uncontrolled cell growth. They can activate signaling pathways that promote cell proliferation and inhibit pathways involved in apoptosis, allowing cancer cells to survive and multiply. Moreover, oncogenes can also influence processes such as angiogenesis, metastasis, and resistance to therapies, further exacerbating the progression of cancer.
Understanding the functions of proto-oncogenes and the role of oncogenes in tumorigenesis is crucial for developing targeted therapies and interventions that can specifically inhibit or modulate their activity. By identifying and targeting the specific oncogenes driving a particular cancer, researchers and clinicians can tailor treatment approaches to individual patients and potentially achieve more effective outcomes.
Role of Mutations in Proto-Oncogenes
Understanding the significance of mutations in proto-oncogenes is crucial for unraveling the molecular mechanisms behind cancer development. These genetic alterations play a pivotal role in driving oncogenesis and the transformation of proto-oncogenes into cancer-causing genes.
Oncogenes and Cancer Development: When proto-oncogenes acquire mutations, they undergo changes that disrupt normal cellular processes, resulting in uncontrolled cell growth and division. These mutated proto-oncogenes, termed oncogenes, drive the initiation and progression of cancer.
Molecular Mechanisms of Oncogenesis: The molecular mechanisms underlying oncogenesis involve various processes, such as enhanced cell proliferation, evasion of cell death, and the promotion of angiogenesis. Mutations in proto-oncogenes can activate signaling pathways that stimulate cell growth, inhibit cell death, and promote tumor vascularization, all of which are hallmarks of cancer.
To better understand the role of mutations in proto-oncogenes, scientists have conducted extensive research and identified specific genetic alterations that contribute to oncogenesis. These include point mutations, gene amplifications, chromosomal translocations, and gene fusions.
Key Mutations in Proto-Oncogenes:
- RAS gene mutations: Mutations in the RAS proto-oncogene, particularly in the KRAS, NRAS, and HRAS subfamilies, are commonly observed in various cancers, including colorectal, lung, and pancreatic cancers.
- EGFR gene mutations: Mutations in the EGFR proto-oncogene are frequently found in lung cancer, leading to dysregulated signaling pathways that promote tumor growth and survival.
- BCR-ABL gene fusion: The BCR-ABL fusion gene, resulting from a chromosomal translocation, is associated with chronic myeloid leukemia (CML) and drives the uncontrolled proliferation of leukemia cells.
These mutations in proto-oncogenes can confer selective growth advantages to cells, promoting their malignant transformation and contributing to the development and progression of cancer. Understanding these molecular mechanisms is crucial for developing targeted therapies that can specifically inhibit the activity of oncogenes, thereby suppressing cancer growth and improving patient outcomes.
Proto-Oncogenes and the Initiation of Cancer
In the complex landscape of cancer initiation, proto-oncogenes play a pivotal role. Proto-oncogenes are normal genes that, under certain circumstances, can undergo mutations or alterations, leading to their activation and subsequent malignant transformation. This initiation process sets the stage for the development of cancerous cells.
When proto-oncogenes are altered, they become oncogenes, which have the potential to drive uncontrolled cell growth and division, a hallmark of cancer. The activation of proto-oncogenes can occur due to various factors, including genetic mutations, environmental exposures, or epigenetic modifications.
Importantly, the malignant transformation of proto-oncogenes is a crucial step in the initiation of cancer. Once oncogenes are activated, they disrupt normal cellular mechanisms, leading to the deregulation of cell cycle control, inhibition of apoptosis, and promotion of angiogenesis.
Table: The Role of Proto-Oncogenes in Cancer Initiation
| Proto-Oncogenes | Malignant Transformation | Cancer Initiation |
|---|---|---|
| Oncogene 1 | Specific mutation | Activation and transformation |
| Oncogene 2 | Epigenetic modification | Dysregulation of cell cycle control |
| Oncogene 3 | Environmental exposure | Inhibition of apoptosis |
The alteration and activation of proto-oncogenes provide the initial impetus for the development of cancer, paving the way for subsequent cellular transformations and progression. Understanding the mechanisms through which proto-oncogenes initiate cancer is crucial for the development of targeted therapies aimed at disrupting these processes.
By identifying and targeting the specific proto-oncogenes responsible for initiating cancer, researchers and clinicians can design interventions that aim to inhibit their activity, ultimately preventing the progression of the disease.
Key Factors Influencing Proto-Oncogene Activation
Proto-oncogenes play a crucial role in the progression of cancer, and their activation is influenced by various factors. Understanding these key factors is essential for comprehending the complex mechanisms underlying tumorigenesis and cancer progression.
Environmental Factors
Environmental factors such as exposure to carcinogens can trigger the activation of proto-oncogenes. Carcinogens can include chemical substances, radiation, and certain viral infections. Carcinogenic substances can directly damage the DNA and cause genetic alterations that activate proto-oncogenes, leading to the development of cancer.
Genetic Factors
Genetic factors contribute significantly to proto-oncogene activation. Mutations or genetic alterations in proto-oncogenes themselves or other genes involved in their regulation can disrupt the normal control mechanisms and result in their aberrant activation. Additionally, inherited genetic mutations can increase the susceptibility to proto-oncogene activation and cancer development.
Epigenetic Factors
Epigenetic modifications, which do not involve changes in the DNA sequence, also play a crucial role in proto-oncogene activation. Epigenetic alterations, such as DNA methylation and histone modifications, can modulate the accessibility of proto-oncogenes, leading to their activation or silencing. These modifications can be influenced by various factors, including aging, diet, lifestyle, and exposure to environmental stimuli.
Factors Influencing Proto-Oncogene Activation
| Factor | Description |
|---|---|
| Environmental Factors | Exposure to carcinogens, such as chemical substances, radiation, and viral infections |
| Genetic Factors | Genetic mutations or alterations in proto-oncogenes and related regulatory genes |
| Epigenetic Factors | Epigenetic modifications, including DNA methylation and histone modifications |
The interplay between these factors is complex and multifaceted, with each factor contributing to the activation of proto-oncogenes and the subsequent development of cancer. Further research is needed to elucidate the intricate relationships between these factors and their impact on tumorigenesis, paving the way for targeted interventions to prevent and treat cancer.
Proto-Oncogenes as Predictive Biomarkers
This section delves into the role of proto-oncogenes as predictive biomarkers in cancer diagnosis and treatment, focusing on the innovative contributions of the Acıbadem Healthcare Group. With their extensive expertise in oncology, Acıbadem Healthcare Group has been at the forefront of utilizing proto-oncogenes as predictive biomarkers to enhance personalized medicine approaches and ultimately improve patient outcomes.
Identifying and Analyzing Proto-Oncogenes
Acıbadem Healthcare Group utilizes state-of-the-art technologies to identify and analyze specific proto-oncogenes that play a crucial role in various types of cancer. By profiling these genes, they can predict the risk of malignancy, guide treatment decisions, and tailor therapy to individual patients. This targeted approach results in more accurate diagnoses and helps healthcare professionals design personalized treatment plans.
Enhancing Cancer Treatment Strategies
The use of proto-oncogenes as predictive biomarkers allows Acıbadem Healthcare Group to optimize cancer treatment strategies. By understanding the genetic alterations and activity of specific proto-oncogenes in individual patients, they can select the most effective therapies and avoid unnecessary treatments. This targeted approach minimizes side effects and maximizes treatment efficacy, improving overall patient outcomes.
The Future of Cancer Care
As research continues, proto-oncogenes hold immense potential for revolutionizing cancer care. Acıbadem Healthcare Group, with its commitment to innovation and patient-centered care, remains at the forefront of utilizing these biomarkers to advance the field of oncology. By harnessing the power of proto-oncogenes and incorporating them into clinical practice, Acıbadem Healthcare Group is paving the way for more precise diagnoses, tailored therapies, and improved survival rates for cancer patients.
Targeting Proto-Oncogenes for Cancer Therapy
In the pursuit of effective cancer treatments, researchers have turned their attention towards targeting proto-oncogenes, which play a crucial role in cancer progression and development. By specifically inhibiting or eliminating the activity of cancer-causing proto-oncogenes, novel therapeutic strategies aim to halt or slow down the advancement of the disease.
Through extensive research, scientists have made notable advancements in developing targeted therapies that focus on proto-oncogenes. By understanding the molecular pathways involved in oncogenesis, researchers have identified potential drug targets and explored various approaches to suppress the activity of proto-oncogenes.
One promising avenue for proto-oncogene targeting is the development of small molecule inhibitors. These inhibitors are designed to selectively bind to the mutated form of proto-oncogenes, preventing them from promoting cancer cell growth and survival. This approach offers the potential for more personalized and precise cancer treatments, minimizing harm to healthy cells and reducing side effects.
Examples of Targeted Therapies:
- BRAF Inhibitors: Developed for specific cancer types like melanoma, these inhibitors target the mutated BRAF proto-oncogene, effectively inhibiting its activity and preventing tumor growth.
- EGFR Inhibitors: These inhibitors target the epidermal growth factor receptor (EGFR) proto-oncogene, which is often overexpressed in various cancers. By blocking EGFR, these therapies disrupt the signaling pathways that promote cancer cell proliferation.
Targeting proto-oncogenes for cancer therapy also holds the potential for combination treatments. By combining targeted therapies with conventional chemotherapy or radiation therapy, a synergistic effect can be achieved. This approach ensures a comprehensive attack on cancer cells, targeting multiple pathways and reducing the likelihood of resistance.
Overall, the development of targeted therapies that specifically address proto-oncogenes is a promising area of research in the fight against cancer. As further insights are gained into the molecular mechanisms underlying oncogenesis, we can anticipate the emergence of more effective and personalized treatments that target the root causes of cancer progression.
| Treatment Approach | Targeted Proto-Oncogenes | Advantages |
|---|---|---|
| BRAF Inhibitors | Mutated BRAF proto-oncogene | – Selective targeting of cancer cells – Reduced side effects compared to conventional chemotherapy – Improved patient outcomes in specific cancer types |
| EGFR Inhibitors | Epidermal growth factor receptor (EGFR) proto-oncogene | – Disruption of cancer cell proliferation pathways – Personalized treatment for EGFR overexpressing cancers |
Emerging Technologies in Studying Proto-Oncogenes
In the field of cancer research, understanding the role of proto-oncogenes in carcinogenesis and the molecular mechanisms of oncogenesis is crucial. Technological advancements have greatly contributed to our knowledge in this area, enabling scientists to delve deeper into the intricate workings of proto-oncogenes. Genomics, proteomics, and other molecular techniques have revolutionized the way we study these critical genes.
Innovative Genomic Approaches
Advancements in genomic technologies have allowed researchers to comprehensively analyze the genetic alterations associated with proto-oncogenes and their impact on cancer development. Whole-genome sequencing techniques provide a detailed map of genetic changes, identifying specific mutations that can transform proto-oncogenes into oncogenes.
Moreover, targeted sequencing approaches, such as exome sequencing and panel sequencing, focus on specific gene regions that are known to harbor proto-oncogenes, providing researchers with detailed information about the genetic alterations that drive oncogenesis. These genomic approaches not only facilitate the identification of cancer-causing mutations but also aid in understanding the intricate relationship between proto-oncogenes and the molecular pathways involved in cancer progression.
Revolutionizing Proteomics
The advent of proteomic technologies has significantly contributed to unraveling the complex protein networks associated with proto-oncogenes. By leveraging mass spectrometry-based techniques, scientists can comprehensively analyze the expression, modifications, and interactions of proteins involved in oncogenesis.
Proteomic studies can identify specific proteins regulated by proto-oncogenes, shedding light on the regulatory mechanisms underlying their oncogenic potential. By analyzing post-translational modifications and protein-protein interactions, researchers can gain insights into key molecular events driving cancer progression.
Integration of Multi-Omics Data
An exciting avenue in the study of proto-oncogenes is the integration of multi-omics data, combining genomics, proteomics, transcriptomics, and epigenomics. This integrative approach allows researchers to identify comprehensive profiles of proto-oncogene alterations and their functional consequences.
By correlating genetic alterations with changes in protein expression and epigenetic modifications, scientists can unravel the intricate mechanisms involved in the transformation of proto-oncogenes into oncogenes. This integrative analysis provides a holistic view of the molecular landscape of carcinogenesis, fostering a better understanding of the complex interplay between genetic and epigenetic factors.
| Advancements in Studying Proto-Oncogenes | Techniques |
|---|---|
| Genomics | Whole-genome sequencing, targeted sequencing (exome sequencing, panel sequencing) |
| Proteomics | Mass spectrometry-based techniques for protein expression and interaction analysis |
| Integration of Multi-Omics Data | Genomics, proteomics, transcriptomics, and epigenomics integration |
These emerging technologies have propelled our understanding of proto-oncogenes and their pivotal role in carcinogenesis. By employing a multidisciplinary approach, scientists can uncover novel insights into the molecular mechanisms of oncogenesis, paving the way for the development of targeted therapies and personalized medicine strategies.
Clinical Implications and Future Directions
This section explores the clinical implications of proto-oncogenes in cancer management and highlights the potential future directions for research. Understanding the role of proto-oncogenes in cancer progression is crucial for developing improved treatment strategies. Let’s delve deeper into the clinical implications and the exciting possibilities that lie ahead.
Clinical Implications of Proto-Oncogenes
Proto-oncogenes play a significant role in the development and progression of various types of cancer. The aberrant activation or mutation of these genes can trigger uncontrolled cell growth, leading to tumor formation. Identifying specific proto-oncogenes and their involvement in cancer can have profound clinical implications:
- Diagnostic Markers: Proto-oncogenes can serve as diagnostic markers for certain types of cancer. Analyzing the expression or presence of specific proto-oncogenes can help in early detection and accurate diagnosis.
- Prognostic Indicators: The presence or activity level of certain proto-oncogenes can provide valuable prognostic information. It can help assess the aggressiveness of the cancer and guide treatment decisions.
- Treatment Targets: Targeting proto-oncogenes can open up new avenues for cancer therapy. Developing drugs or interventions that specifically inhibit or neutralize the activity of these cancer-promoting genes can aid in personalized treatment approaches.
Future Directions for Research
Continued research on proto-oncogenes and their involvement in cancer development is crucial for advancing our understanding and improving patient outcomes. Here are some promising future directions in this field:
- Identification of Novel Proto-Oncogenes: Despite significant progress in identifying proto-oncogenes, there is still much to explore. Future research may uncover new genes and molecular pathways involved in cancer progression.
- Elucidating Mechanisms of Action: Understanding the precise mechanisms through which proto-oncogenes drive cancer development can reveal potential therapeutic targets and lead to the development of more effective treatments.
- Implementation of Personalized Medicine: Further research on proto-oncogenes can pave the way for personalized medicine approaches. By identifying specific proto-oncogenes in individual patients, tailored treatment plans can be developed for improved outcomes.
| Proto-Oncogenes | Clinical Implications |
|---|---|
| MYC | Predictive marker for aggressive cancers |
| BRAF | Potential target for precision therapies |
| RAS | Predictive marker for poor prognosis |
As research in the field of proto-oncogenes progresses, we can expect novel insights and breakthroughs that will revolutionize cancer management. By unraveling the complexities of proto-oncogenes and their role in cancer development, we can pave the way towards more precise diagnostics, targeted therapies, and improved patient outcomes.
Proto-Oncogenes: Requirements to Cause Cancer
Importance of Early Detection and Prevention
The role of cancer-causing proto-oncogenes and their contribution to tumorigenesis cannot be understated. Early detection and prevention play a crucial role in minimizing the impact of proto-oncogenes on cancer development. By identifying individuals at risk and implementing effective preventive measures and screening techniques, we can intervene early and potentially prevent the progression of proto-oncogene-related cancers.
Proto-Oncogenes: Requirements to Cause Cancer
The Significance of Early Detection
- Early detection allows for timely intervention and treatment, potentially improving patient outcomes.
- Screening tests can detect cancer at an early stage, when it is more likely to be curable.
- Early detection enables targeted therapies and personalized medicine approaches, leading to more effective treatment strategies.
- Identifying individuals at high risk of developing proto-oncogene-related cancers allows for proactive monitoring and preventive interventions.
Preventive Measures for Proto-Oncogene-Related Cancers
- Lifestyle modifications, such as maintaining a healthy weight, adopting a balanced diet, and avoiding tobacco and alcohol, can reduce the risk of cancer development.
- Vaccinations, such as the HPV vaccine to prevent HPV-associated cancers, can be administered to individuals at risk.
- Regular screenings and check-ups can help detect cancer in its early stages, allowing for immediate treatment.
- Genetic counseling and testing can identify individuals with specific genetic mutations associated with increased cancer risk, facilitating personalized prevention strategies.
| Benefits of Early Detection and Prevention | Actions for Early Detection and Prevention |
|---|---|
| Improved patient outcomes | Lifestyle modifications |
| Higher chances of curability | Vaccinations |
| Targeted therapies and personalized medicine | Regular screenings and check-ups |
| Proactive monitoring for high-risk individuals | Genetic counseling and testing |
Conclusion
To cause cancer, proto-oncogenes require specific conditions and genetic alterations. Throughout this article, we have explored the role of proto-oncogenes in carcinogenesis and their significance in cancer development. Understanding the requirements for proto-oncogenes to transform into cancer-causing genes is crucial for advancing our knowledge and developing targeted interventions.
By studying the functions of proto-oncogenes and their molecular mechanisms, we can gain valuable insights into cancer progression. Mutations in proto-oncogenes play a pivotal role in initiating the development of cancerous cells. Factors such as environmental influences and genetic variations can activate proto-oncogenes, leading to malignant transformations.
Proto-oncogenes also serve as predictive biomarkers, enabling personalized medicine approaches in cancer diagnosis and treatment. Targeted therapies aimed at suppressing the activity of cancer-causing proto-oncogenes hold promise in cancer therapy. Emerging technologies in genomics and proteomics have further enhanced our understanding of proto-oncogenes and their involvement in carcinogenesis.
As we move forward, continued research in this field is crucial to unlocking the full potential of proto-oncogenes as diagnostic and therapeutic targets. Early detection and prevention strategies are vital in minimizing the impact of cancer-causing proto-oncogenes. By prioritizing research and implementing preventive measures, we can work towards reducing the burden of proto-oncogene-related cancers and improving patient outcomes.
Proto-Oncogenes: Requirements to Cause Cancer
FAQ
What are proto-oncogenes?
Proto-oncogenes are normal genes that play a crucial role in regulating cell growth and division. They can become cancer-causing oncogenes when they undergo certain genetic changes or mutations.
What are the requirements for proto-oncogenes to cause cancer?
To cause cancer, proto-oncogenes require specific alterations or mutations that lead to their activation or overexpression. These changes can occur due to genetic, environmental, or epigenetic factors, among others.
How do proto-oncogenes contribute to carcinogenesis?
Proto-oncogenes are involved in the process of carcinogenesis, which is the development of cancer. When proto-oncogenes are mutated or activated, they can drive abnormal cell growth, invasion, and other characteristics associated with cancer.
What is the role of oncogenes in tumorigenesis?
Oncogenes, which are activated forms of proto-oncogenes, play a critical role in initiating and promoting the formation of tumors. They can cause uncontrolled cell growth, inhibit cell death, and promote angiogenesis, all of which contribute to tumor development.
How do mutations in proto-oncogenes lead to cancer?
Mutations in proto-oncogenes can result in the overactivation of their protein products, leading to abnormal cell signaling and uncontrolled cell growth. These mutations can be acquired or inherited and are associated with the development of various types of cancer.
How do proto-oncogenes initiate cancer?
Proto-oncogenes can initiate cancer by acquiring specific mutations or alterations that disrupt the normal regulation of cell growth and division. These changes can lead to the transformation of normal cells into cancerous cells and the initiation of tumor formation.
What factors influence the activation of proto-oncogenes?
The activation of proto-oncogenes can be influenced by various factors, including genetic predisposition, exposure to carcinogens, viral infections, hormonal imbalances, and epigenetic modifications. These factors can trigger the activation of proto-oncogenes and contribute to cancer progression.
How can proto-oncogenes be used as predictive biomarkers?
Specific proto-oncogenes can serve as predictive biomarkers in cancer diagnosis and treatment. Their identification and analysis can help determine the prognosis, predict treatment response, and guide personalized medicine approaches for improved patient outcomes.
Are there targeted therapies for proto-oncogenes in cancer treatment?
Research is ongoing to develop targeted therapies that aim to suppress or eliminate the activity of cancer-causing proto-oncogenes. These therapies focus on inhibiting the oncogenic signaling pathways associated with proto-oncogenes, offering potential treatment options for certain types of cancer.
What technologies are used to study proto-oncogenes?
The study of proto-oncogenes involves various advanced technologies, such as genomics, proteomics, and molecular techniques. These technologies help researchers understand the molecular mechanisms of proto-oncogenes, their role in carcinogenesis, and identify potential therapeutic targets.
What are the clinical implications of proto-oncogenes in cancer management?
Proto-oncogenes have important clinical implications in cancer management. They can aid in early detection, risk assessment, and personalized treatment strategies. Further research on proto-oncogenes may lead to the development of innovative diagnostic and therapeutic approaches.
Why is early detection and prevention important in relation to proto-oncogenes?
Early detection and prevention play a crucial role in reducing the impact of proto-oncogenes on cancer development. Timely screening, risk assessment, and lifestyle modifications can help identify individuals at risk and intervene early, potentially preventing the progression of proto-oncogene-related cancers.
ACIBADEM Healthcare Group Hospitals and Clinics
With a network of hospitals and clinics across 5 countries, including 40 hospitals, ACIBADEM Healthcare Group has a global presence that allows us to provide comprehensive healthcare services to patients from around the world. With over 25,000 dedicated employees, we have the expertise and resources to deliver unparalleled healthcare experiences. Our mission is to ensure that each patient receives the best possible care, supported by our commitment to healthcare excellence and international healthcare standards. Ready to take the first step towards a healthier future? Contact us now to schedule your Free Consultation Health session. Our friendly team is eager to assist you and provide the guidance you need to make informed decisions about your well-being. Click To Call Now!*The information on our website is not intended to direct people to diagnosis and treatment. Do not carry out all your diagnosis and treatment procedures without consulting your doctor. The contents do not contain information about the therapeutic health services of Acıbadem Health Group.
